đź“‹ FDA Reference
corday coronary sinus infusion catheter
Retroperfusion Systems
Summary: The Corday Coronary Sinus Infusion Catheter is used for retrograde coronary sinus perfusion in cardiac procedures. It is primarily used by cardiologists in interventional settings.
FDA Clearance Information
Pathway
510K
Number
K865074 ↗
Decision Date
May 6, 1987
Product Code
DQY
Device Class
Class 2
Evidence
0 studies
The Corday Coronary Sinus Infusion Catheter was cleared through the FDA 510(k) pathway on May 6, 1987. It is manufactured by Retroperfusion Systems and classified as a Class 2 device.
What It Is
The Corday Coronary Sinus Infusion Catheter is a specialized catheter designed for retrograde infusion of solutions into the coronary sinus. This technique is used to deliver therapeutic agents directly to the heart muscle, potentially improving myocardial perfusion during ischemic events. The catheter features a balloon that can be inflated to prevent backflow, ensuring targeted delivery of the infusion.
Clinical Applications
This catheter is commonly used in interventional cardiology, particularly during procedures aimed at enhancing myocardial perfusion in patients with coronary artery disease. It is often utilized in settings where direct coronary artery access is challenging or when additional myocardial perfusion is needed. The device is suitable for use in adult patients undergoing cardiac interventions.
Indications for Use
The catheter is indicated for use in procedures requiring retrograde infusion into the coronary sinus, such as during myocardial ischemia. It is designed for patients who may benefit from enhanced myocardial perfusion, particularly in cases where traditional antegrade methods are insufficient.
Practical Considerations
The catheter typically comes in various sizes to accommodate different patient anatomies. It is compatible with standard infusion systems and requires careful placement to ensure effective delivery. Clinicians should be trained in its use to avoid complications such as improper balloon inflation.
Related Literature
The linked study investigated the use of retrograde coronary venous contrast echocardiography in dogs to assess myocardial perfusion. It found that retrograde injections after coronary occlusion resulted in significant myocardial opacification, suggesting potential benefits in ischemic conditions. However, the study was limited to an animal model, and results may not directly translate to human patients.
Frequently Asked Questions
What is the Corday Coronary Sinus Infusion Catheter used for?
It is used for retrograde infusion of therapeutic agents into the coronary sinus to enhance myocardial perfusion.
What specialties typically use this device?
Interventional cardiologists primarily use this device during cardiac procedures.
What are the FDA-cleared indications?
The device is indicated for retrograde coronary sinus infusion to improve myocardial perfusion in ischemic conditions.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.